Resonance Health Limited, a healthcare technology and services company, designs, develops, and manufactures software-as-medical devices in the Asia Pacific, North America, South America, Europe, the Middle East, and Africa. It offers FerriScan, a non-invasive MRI based system for quantifying liver iron concentration (LIC); FerriSmart, an artificial intelligence (AI) assisted device for the automated real-time assessment of LIC; HepaFat-AI, an AI-assisted device for the automated real-time multi-metric measurement of liver-fat; CardiacT2, a dual analysis service with FerriScan for assessing heart iron loading; HepaFat-Scan, a non-invasive MRI-based solution for the assessment of liver-fat in liver tissue; and LiverSmart, a non-invasive MRI-based multi-parametric device combining FerriSmart and HepaFat-AI into a consolidated report. It also offers quantitative imaging measurements and CRO, such as quality-assured image analysis, imaging charter development, project and data management, issue resolution, site tracker and clinical trial progress report, and coordination of data flow services; biomarkers, blood, urine, and protein analytes, as well as RNA, DNA, and genotyping services; and protocol development, assessment of subject inclusion or exclusion, decisions on dose modifications, and evaluating the safety profile of a new therapy, as well as supporting primary and secondary end-points demonstrating drug efficacy services for multinational and multicenter clinical trials; and phantoms for the calibration of MRI machines. The company serves clinicians for the management of human diseases; and pharmaceutical and therapeutic companies for their clinical trials. Resonance Health Limited was incorporated in 1987 and is headquartered in Burswood, Australia.

Mr. Ajay  Nair

General Manager of Global Sales & Marketing

Mr. Chad  Tondut

Communications Manager and GM of Products & Portfolio

Mr. Benjamin  Carruthers

Chief Financial Officer

Ms. Liesl  Ellies

General Counsel

Mr. Mitchell M. Wells B.Com., B.Comm, L.L.B., LLB

Company Secretary & Non Executive Director

Dr. Sherif  Boulos Ph.D.

Chief Scientific Officer of Molecular

Mr. Andrew Duncan Harrison BCom (Hons), MAICD

Chief Executive Officer

Dr. Timothy Guy St. Pierre B.Sc(Hons), Ph.D.

Chief Research Scientist

Dr. Wenjie  Pang Ph.D.

Chief Scientific Officer  Imaging & AI

Nosaukums	Tirgus kapitalizācija
Optomed Oyj	0M
Vaso Corporation	0M
Global Health Limited	0M
SHL Telemedicine Ltd.	0M
OneLife Technologies Corp.	0M
Health Catalyst, Inc.	0M
TruBridge, Inc.	0M
M3, Inc.	0M
RaySearch Laboratories AB (publ)	0M
Induction Healthcare Group PLC	0M
GE HealthCare Technologies Inc.	0M

Resonance Health Limited

Resonance Health Limited Konkurentu saraksts

Galvenie konkurenti